Verify Account

The global generic drug industry is robust and growing. The total value of the global generic drug industry has crossed $900 billion in 2016, and is poised to cross the coveted $1 trillion soon. However, the generic sector is not very concentrated, with the top ten global generic companies accounting for about only 38 percent of the total value. Furthermore, only four companies — Mylan, Teva, Sandoz, Pfizer (General and Established Products) Generics division, and Sun Pharma, have a truly global presence. Why is it that only four out of the many generic drug companies are global, and the rest are not? What are the success secrets of these companies? Do they have a separate Success DNA? A Code for winning in the global generic drug markets? Can any of the other companies become global?